Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yes, thankyou rdfdr1. you are right you are right you are right all along, i am wrong i am wrong i am wrong wrong wrong. Do billionaires have a "sense" of common "cents" in their priorities as in health/wealth ratio/values? :)
Would naked shorters "if" they exist be concerned-resentful if a higher OCAT competitive bid comes in? What would happen? Would they rather be happy with $8.50 than higher? Do they have a merited position if OCAT helps millions with the benefits OCAT has achieved in medical solutions and patents?
Once a wealth-guy named Bob Hope was approached by a armed mugger and told, "your money or your life". After several minutes of silence the mugger said, well what is your decision and nudged with the weapon. Bob Hope said, I'm thinking i'm thinking.
If you had 32 billion dollars what percentage of value of that 32 billion could be leveraged quantified into health benefits? Is Health of value to a dieing billionaire? If i had 32 billion i would pay for personal attention and create benefits for millions of others. One person can make a tremendous impact.
Do billionaires become patients themselves sometimes? Do billionaire patients like the "current healthcare options" available to them? What could OCAT bring to a billionaire? What could OCAT bring to millions of patients in need? Is someone attempting to fool current shareholders about the true "future value" of OCAT?
Do competitors of OCAT have these abilities that OCAT has?
1) the ability to halt the progression of AMD and SMD in FDA/EMA approved clinical trials.
2) the ability to provide significant visual acuity improvement in FDA/EMA approved clinical trials.
3) the ability to dramatically reverse MS in rats studies
4) the ability to make scalable, universal blood and platelets
5) the ability to show remission in canine's with Crohn's Disease
6) the ability to preserve kidney function and extend the lifespan of mice with lupus
OCAT has some execellent accomplishments.
Dr. Lanza and his incredible scientific team has shown the following in documented and published papers over the past few years:
1) the ability to halt the progression of AMD and SMD in FDA/EMA approved clinical trials.
2) the ability to provide significant visual acuity improvement in FDA/EMA approved clinical trials.
3) the ability to dramatically reverse MS in rats studies
4) the ability to make scalable, universal blood and platelets
5) the ability to show remission in canine's with Crohn's Disease
6) the ability to preserve kidney function and extend the lifespan of mice with lupus
I have a lot of respect for Bogeyfree's efforts and action. It is much different approach than i see from others.
"
An Open Letter to Alphabet and Mr. Zuckerberg,
It is clear that both of your organizations and leadership teams think very differently than most of the rest of your peers. Your organization's culture is all about making a true difference in the lives of people everywhere.
You are not wrapped up in the politics and being politically correct but have always shown true leadership in thinking outside the box with the goal of leapfrogging the status quo with the end result to make a real difference.
Because of your mindset I wanted to share with you a science that IMO is truly game changing and has a high probability of changing medicine in a big way but unfortunately this science is being sold off to a Japanese firm for peanuts.
The science is that of Dr. Robert Lanza, probably the leading pluripotent scientist on the planet. Dr. Lanza and his team have over 130 patents and pending patents that cover almost all cell types derived from an embryo and IPSC. Dr. Lanza's science uses the earliest and most powerful stem cells which as you know means virtually every cell type can be produced on an efficient, scalable and unlimited basis due to the early cells ability to reproduce forever. But what makes his science a win win for society is he has also perfected and patented the ability to extract a single cell from a blastomere WITHOUT harming the embryo.
Dr. Lanza and his incredible scientific team has shown the following in documented and published papers over the past few years:
1) the ability to halt the progression of AMD and SMD in FDA/EMA approved clinical trials.
2) the ability to provide significant visual acuity improvement in FDA/EMA approved clinical trials.
3) the ability to dramatically reverse MS in rats studies
4) the ability to make scalable, universal blood and platelets
5) the ability to show remission in canine's with Crohn's Disease
6) the ability to preserve kidney function and extend the lifespan of mice with lupus
His firm, Ocata Therapuetics is currently under a tender offer that expires Dec 16, where all of this science is being sold for a ridiculous price of $379M. Yes you are reading this right, all of this science and therapies are available for as little as $380M.
My appeal to you is, your teams are the true forward thinkers on this planet, your teams care deeply about making a real difference in the lives of billions and your organization's have the capability to fund and drive this science to a level no one could imagine.
If Dr. Lanza is right, his patented science will revolutionize medicine forever and bring real cures to the people but it needs a catalyst and fast and this is where I hope you will step in.
$379M is an absolute steal to control all of this science and these cells that can treat hundreds of diseases. His science will support almost all eye diseases, hundreds of auto immune diseases and mass produce universal blood/platelets.
There is no bigger opportunity to control a huge segment of regenerative medicine that can change the lives of billions let alone what this could mean to dramatically reducing future healthcare costs.
I hope you somehow read this and will immediately ask your teams to look into Dr. Lanza and Ocata Therapeutics, as bringing real game changing solutions to the masses is your culture, it is in your DNA!
Alphabet and Facebook, you are the new visionaries and leaders in this country and I implore you to take on what most say is impossible and that is revolutionize medicine by being the catalyst to take Dr. Lanza's broad, deep and patented regenerative medicine science to the forefront of healthcare and drive change now!
P.S. - Mr. Zuckerberg, congratulations on the birth of your first child as there is no greater joy. Likewise there is no greater gift, than the gift of bringing real cures to all including your child as he grows up in this world!"
Thanks for listening,
BF
If you decided to be a boxer, perhaps you have not freely chosen the highest standards for living that builds and values and improves rather than destroys. OCATs Lanza/Team are doing these amazing traits of character.
Something to consider: Quitters never win and winners never quit. Bidding wars and re-evaluations happen. "true-statement".
fruition
noun
1.
the attainment or realization of something worked for or desired; fullfilment
2.
enjoyment of this
3.
the act or condition of bearing fruit
Some know that a higher-valuation could "also" change-things-quickly.
The meaning of supporting OCAT Patients/LanzaTeam success has a since of purpose beyond the ego. Do animals have a lower since of purpose?
BS the possibility of a Bidding Situation exist. "Surely" Silicon Valley A rated Bank likes OCAT and put big money in OCAT. When you go on EBAY most bidders wait till the last minute and then many bids come in if the value is there. OCAT has Tremendous VALUE !!!
Do you believe the Lancet Journal and it's agreement in OCAT's amazing advancements? Is your imagination limited? Is it limiting others imagination? It takes more courage to believe "good happens" then to be a skeptical individual.
Is it ok to say BS? Bidding Situations/ wars most likely happen towards the last minute IMO.
OCAT has a lot going for patients and itself. Thinking about bidding war myself as the reward would be great.
If you want to go there then you might consider taking a course about the Japanese language.
Do you want instant gratification? Does it make since for anyone to undermine this interesting amazing scientific news?
Raise ones standards, raise ones life.
http://ir.ocata.com/press-releases/detail/2800
Keeping in OCAT as things are getting interesting.
http://ir.ocata.com/press-releases/detail/2800
Stemvest found this about Astellas
"Here's a nice summary of the OSI acquisition:
Astellas buys OSI Pharma for $4 billion in cancer push | Reuters"
http://www.reuters.com/article/2010/05/17/us-osi-astellas-idUSTRE64G06J20100517#es3XkSfrfRlZmJAE.97
microcap found this
"Wow, Check out this blast from the past from 2010 when Astellas Pharma Extends a Tender Offer for OSI Pharma Amid Weak Shareholder Response to the shares that values the U.S. cancer drug developer at $3.5 billion. Stay the course we still have a ways to go with our OCAT venture or should I say misadventure."
Thanks Lasers, got a green OCAT feeling now.
Keeping in mind all the past obsfuscations that-seemed-unsurmountable but turned out different. In the event that OCAT goes on to major success beyond current "situation" or appearance. A competitive bid or other unknown possibilities can make this little temporary obsfuscation be viewed as insignificant and propel OCAT towards the vision.
Good to see OCAT's Dr. Lanza stay the course and tweet about his report today. Thanks to him and his team we have opportunity and patients have potential brighter future.
Multiplication of appreciation welcomed. Astellas knows the way, now will they pay for it. Other companies are in a position to recognize what Astellas recognizes.
Thanks anselab, OCAT's Dr. Lanza is brilliant. Many people can be helped. Best to you anselab.
I checked with Churchill at Corporate Office: (877)937-7110
He said no way, not true.
OCAT value is really worth "10x now" and another 10x to make it through phase2. To them who have ears...from back in 2013 OCAT's Matt Vincents Mouth before OCAT phase 1 success recorded in Lancet Peer Reviewed Scientific Journal.
Why would China invite OCAT to China? What purpose? Why would Japan not value OCAT's NED technology enough to remunerate share holders decently?
http://www.iddst.com/iddst2015/ScientificProgram9.asp
Title: Moving Pluripotent Stem Cell Therapies to the Clinic: Retinal Cells for the Treatment of Eye Diseases
Dr. Shi-Jiang (John) Lu, Senior Director of Research, Ocata Therapeutics, Inc., USA
Have the benefits of the OCAT Science patent advancements ever in all your years of posting been of value to you or a factor? I've not seen it from you.
Post from ablidy:
"Just thinking , about Ocata's physical assists not IP...... How do you valuate the frozen cells that are already manufactured under FDA GMP conditions , ready to go into patients for cures ...... Paul said that they were going to get 6 figures at the ASM in Boston in 2014 ..... I was there...... we have transcripts
Now my math is 50,000 units dose ( low ball figure( times $100,000 is equal to $5, 000,000,000 billion USD for AMD /SMD and MMD of RPE ..... Where is this? We paid for this inventory as shareholders ? How do you account for this as a CFO when you report the 14D....and is it in the report .......would you have to pay taxes on this inventory ?....."
surprise happens...competitive bidders happen...bidding wars happen...OCAT has this possible opportunity to be part of the above. :)
There are those that would like a share count to determine if illeagle shorting has underminded the OCAT/Lanza/Teams/Science that has remarkable historical data written up in the Lancet Peer Reviewed Scientific Journal that could help millions with, current, unmet medical needs.
Could OCAT Feb. options lead to eventual bidding-war? Anything is possible and achievable when one puts their mind and action into it.
The fact that OCAT went to CHINA to show the NED wares is considered action.
http://www.iddst.com/iddst2015/ScientificProgram9.asp
With OCATA's NED "no-embryo-destroyed" method, will China make a bid?
Do we see a connection here? PFE AGN Roche and REGN have an interest in eyesight maintenance and treatment.
http://www.iddst.com/iddst2015/ScientificProgram9.asp
Title: Moving Pluripotent Stem Cell Therapies to the Clinic: Retinal Cells for the Treatment of Eye Diseases
Dr. Shi-Jiang (John) Lu, Senior Director of Research, Ocata Therapeutics, Inc., USA
Lasers, you are clearly doing a good job with your OCAT post. Thankyou for your "facts" and information you give. Potentially, a lot to gain here.
The relative rate of importance of supportive facts are keeping OCAT in the green.
OCAT's Phase 1 better patients data or first injection in Phase 2 perhaps. So many possibilities like competitive offer or raise of current buyout offer.
Well said Lasers.
"$OCAT +150 Patents + Patents Appl will control most of the future Pharma Drugs based on Stem Cell Cures of disease and aging.
A $1.0 billion offer for $OCAT would be $24 PPS and easily handled by Astellas cash on hand. A $1.0 billion offer is pocket change for the world's largest Pharma namely Pfizer."
Buyout or Partnerships have always been in the realm of valid direction for this company. For those that have listened to the early meetings on partnering/buyouts with Matt Vincent in the mix, they know the above to be true. PFE AGN Roche and REGN have an interest in eyesight maintenance and treatment.
If bidding war happens then the below is valid.
Here is an OCAT quote/post:
"Just thinking. Maybe Wooten isn't the scoundrel he seems to be. Maybe the $8.50 give away was just bait set out for other potential suitors to poop or get off the pot? Worst case scenario: the #$%$ get the company for a song, we get $8.50/ share. Best case scenario: #$%$ get $11,000,000 present and we get a lot more than $8.50. All my disappointments should be like this!"
Lode we both think the science is brilliant. The competitors can not afford for "anyone" to have this Intellectual Property. Supply and demand has taken the share price over the buyout offer. Bidding war seems plausible. IMO
Thanks-for the info North40000. Good to see green, OCAT 200day moving average is turning up. PFE AGN Roche and REGN are interested in eyesight maintenance and treatment.
For Lasers information, he has got me thinking now on other possibilities. No wonder OCAT is trading higher than the offer in from the large pharma from JAPAN.
Who would you feel most sorry for, a person that naked shorted a stock that turned out to have huge value or a patient that had to fly all the way to Japan for highest quality cells, better than bone marrow cells?
Achievements
"OCATA Therapeutics"
(MA, USA;
and its collaborators have discovered
a new method to generate a potent and replenishable population of MSCs from pluripotent stem cells
[1]
.
This new and proprietary population of pluripotent
stem cell-derived MSCs display potent immunomod
-
ulatory and therapeutic properties and has a greater
than 30,000-fold proliferative capacity, relative to ordi
-
nary bone-marrow-derived MSCs, the most commonly
used source for MSCs in clinical trials.
LOL yes OCAT has Brilliant-Science. Those that did not value OCAT before the offer were betting on 0.00, now they are hoping to keep their losses down to a minimum of what a bidding war would do to them. IMO If OCAT does not have huge value then why would there even be an offer?